Cerebellar Alterations and Gait Defects as Therapeutic Outcome Measures for Enzyme Replacement Therapy in α-Mannosidosis
Open Access
- 1 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 70 (1), 83-94
- https://doi.org/10.1097/nen.0b013e31820428fa
Abstract
α-Mannosidosis is a rare lysosomal storage disease with accumulation of undegraded mannosyl-linked oligosaccharides in cells throughout the body, most notably in the CNS. This leads to a broad spectrum of neurological manifestations, including progressive intellectual impairment, disturbed motor functions, and cerebellar atrophy. To develop therapeutic outcome measures for enzyme replacement therapy that could be used for human patients, a gene knockout model of α-mannosidosis in mice was analyzed for CNS pathology and motor deficits. In the cerebellar molecular layer, α-mannosidosis mice display clusters of activated Bergman glia, infiltration of phagocytic macrophages, and accumulation of free cholesterol and gangliosides (GM1), notably in regions lacking Purkinje cells. α-Mannosidosis brain lysates also displayed increased expression of Lamp1 and hyperglycosylation of the cholesterol binding protein NPC2. Detailed assessment of motor function revealed age-dependent gait defects in the mice that resemble the disturbed motor function in human patients. Short-term enzyme replacement therapy partially reversed the observed cerebellar pathology with fewer activated macrophages and astrocytes but unchanged levels of hyperglycosylated NPC2, gangliosides, and cholesterol. The present study demonstrates cerebellar alterations in α-mannosidosis mice that relate to the motor deficits and pathological changes seen in human patients and can be used as therapeutic outcome measures.Keywords
This publication has 56 references indexed in Scilit:
- Impaired Lysosomal Trimming of N-Linked Oligosaccharides Leads to Hyperglycosylation of Native Lysosomal Proteins in Mice with α-MannosidosisMolecular and Cellular Biology, 2010
- Automatic analysis of altered gait in arylsulphatase A-deficient mice in the open fieldBehavior Research Methods, 2009
- Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouseExperimental Neurology, 2009
- Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosisBrain Research, 2009
- Enzyme Replacement Improves Ataxic Gait and Central Nervous System Histopathology in a Mouse Model of Metachromatic LeukodystrophyMolecular Therapy, 2009
- Alpha-mannosidosisOrphanet Journal of Rare Diseases, 2008
- Gangliosides Trigger Inflammatory Responses via TLR4 in Brain GliaThe American Journal of Pathology, 2006
- Neurocognitive and Psychotiform Behavioral Alterations and Enhanced Hippocampal Long-Term Potentiation in Transgenic Mice Displaying Neuropathological Features of Human α-MannosidosisJournal of Neuroscience, 2005
- Neurology of adult alpha-mannosidosis.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- An immunohistochemical study on the ontogeny of cells immunoreactive for spot 35 protein, a novel Purkinje cell-specific protein, in the rat cerebellumDevelopmental Brain Research, 1986